opal AT lists.psi.ch

Subject: The OPAL Discussion Forum

List archive

[Opal] Genetic Test for Gynecological Tumors Susceptibility

From: CD Genomics <customer AT cdgenomics-mail.com>
To: opal AT lists.psi.ch
Subject: [Opal] Genetic Test for Gynecological Tumors Susceptibility
Date: Fri, 11 Apr 2014 12:06:14 +0000 (UTC)
List-archive: <https://lists.web.psi.ch/pipermail/opal/>
List-id: The OPAL Discussion Forum <opal.lists.psi.ch>

Email not displaying correctly? View it in your browser

Dear Friends,
CD Genomics offers genetic test panel which tests the dominant inheritance and mutations of some of the critical genes that are highly related to the susceptibility risks of several tumors.

What kinds of diseases are you susceptible to?

GenSeq^TM Gynecological Tumors Susceptibility Panel
Breast/Ovarian Cancer:	Sequencing the whole exons of BRCA1,BRCA2 and XRCC2 genes
Ovarian Cancer:	Sequencing the whole exons of BRCA1,BRCA2 and RAD51C genes
Endometrial cancer:	Sequencing the whole exons of MLH1,MSH2, MSH6 and PMS2 genes

	Services Objectives Sequencing and comprehensive analysis of the susceptibility genes for Gynecological tumors (breast cancer, ovarian cancer, or endometrial cancer). Prediction on risks of Gynecological tumors and recommendations on early prevention and diagnosis.
Service Subjects All women, especially those with a family history of breast cancer, ovarian cancer, or endometrial cancer. Patients suffering from early-onset (less than 40 years old) breast cancer, ovarian cancer, or endometrial cancer.

By knowing more about your underlying health risks, you and your doctor can make more informed decisions about your healthcare.

Sincerely,
Anna Messer
Customer Service
CD Genomics
45-16 Ramsey Road Shirley, NY 11967, USA
Tel: 1-631-626-9181
Fax: 1-631-614-7828
Email：info AT CD-Genomics.org

To unsubscribe please click here

[Opal] Genetic Test for Gynecological Tumors Susceptibility, CD Genomics, 04/11/2014